Buscar resultados de ensayos clínicos
Multiple Sclerosis, Relapsing-Remitting - 32 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: An Observational Study for the Assessment of Compliance and Persistence to Rebif® Therapy of Patients With Relapsing-remitting Multiple Sclerosis (MS) and Evaluation of Potential Factors Influencing These Parameters Condición: Multiple Sclerosis, Relapsing-Remitting Fecha: 2010-04-26 |
Completed |
Nombre del estudio: A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis Condición: Multiple Sclerosis, Relapsing-Remitting Fecha: 2007-02-26 Intervenciones:
|
Completed |
Nombre del estudio: A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis Condición: Multiple Sclerosis, Relapsing-Remitting Fecha: 2002-12-19 Intervenciones:
|
Terminated |
Nombre del estudio: Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS] Condición: Multiple Sclerosis, Relapsing-Remitting Fecha: 2010-05-28 Intervenciones:
|
Completed |
Nombre del estudio: A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS) Condición: Multiple Sclerosis, Relapsing-Remitting Fecha: 2006-02-13 Intervenciones:
|
Completed |
Nombre del estudio: Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis Condición: Multiple Sclerosis, Relapsing-Remitting Fecha: 2013-01-17 Intervenciones:
|
Completed |
Nombre del estudio: Melatonin in Relapsing-Remitting Multiple Sclerosis Patients Condición: Multiple Sclerosis, Relapsing-Remitting Fecha: 2011-01-18 Intervenciones: Drug: Melatonin 3mg oral, daily, one hour before sleep |
Enrolling by invitation |
Nombre del estudio: Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS) Condición: Multiple Sclerosis, Relapsing-Remitting Fecha: 2015-07-02 Intervenciones: Drug: Domperidone Addition of Domperidone to current Disease Modifying Therapy. |
Completed |
Nombre del estudio: Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012 Condición: Multiple Sclerosis, Relapsing-Remitting Fecha: 2015-10-16 Intervenciones: Drug: dimethyl fumarate dimethyl fumarate administered as per the arm description |
Completed |
Nombre del estudio: Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition Condición: Multiple Sclerosis, Relapsing-Remitting Fecha: 2015-11-04 |